OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
State of the Art in Epitope Mapping and Opportunities in COVID-19
Samira M. Hamed, Masarra M. Sakr, Ghadir S. El-Housseiny, et al.
Future Science OA (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Samira M. Hamed, Masarra M. Sakr, Ghadir S. El-Housseiny, et al.
Future Science OA (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Showing 11 citing articles:
Vaccines reimagined: The peptide revolution in disease prevention
Vivek P. Chavda
Progress in molecular biology and translational science (2025)
Closed Access
Vivek P. Chavda
Progress in molecular biology and translational science (2025)
Closed Access
Technical pitfalls when collecting, cryopreserving, thawing, and stimulating human T-cells
Daniel J. Browne, Catherine Miller, Denise L. Doolan
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Daniel J. Browne, Catherine Miller, Denise L. Doolan
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development
Fabrizio Angius, Silvia Puxeddu, S Zaimi, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 17-17
Open Access | Times Cited: 3
Fabrizio Angius, Silvia Puxeddu, S Zaimi, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 17-17
Open Access | Times Cited: 3
BBIBP-CorV Vaccination against the SARS-CoV-2 Virus Affects the Gut Microbiome
Yang Shen, Ying Dong, Jie Jiao, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 942-942
Open Access | Times Cited: 7
Yang Shen, Ying Dong, Jie Jiao, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 942-942
Open Access | Times Cited: 7
Peptide-ligand conjugate based immunotherapeutic approach for targeted dismissal of non-structural protein 1 of dengue virus: A novel therapeutic solution for mild and severe dengue infections
Varshita Srivastava, Priya Godara, Sudip Prasad Jena, et al.
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129562-129562
Closed Access | Times Cited: 2
Varshita Srivastava, Priya Godara, Sudip Prasad Jena, et al.
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129562-129562
Closed Access | Times Cited: 2
Natural Antibodies Produced in Vaccinated Patients and COVID-19 Convalescents Recognize and Hydrolyze Oligopeptides Corresponding to the S-Protein of SARS-CoV-2
Anna M. Timofeeva, Sergey E. Sedykh, Tatyana A. Sedykh, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1494-1494
Open Access | Times Cited: 5
Anna M. Timofeeva, Sergey E. Sedykh, Tatyana A. Sedykh, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1494-1494
Open Access | Times Cited: 5
Lessons from COVID‐19: Aspects of prevention, therapeutics, and diagnostics against SARS‐CoV‐2 with special focus on JN.1 and XBB sublineages
Puja Jaishwal, Upagya Gyaneshwari, Kisalay Jha, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 1
Puja Jaishwal, Upagya Gyaneshwari, Kisalay Jha, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 1
Monitoring the VDPV2 outbreak in Egypt during 2020–2021 highlights the crucial role of environmental surveillance and boosting immunization in combating Poliovirus
Menna R. Shabana, Amira Y. Zaghloul, Tamer H. El Shaarawy, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Menna R. Shabana, Amira Y. Zaghloul, Tamer H. El Shaarawy, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Reverse Vaccinology and Immunoinformatic Approach for Designing a Bivalent Vaccine Candidate Against Hepatitis A and Hepatitis B Viruses
Neda Ahmadi, Mohammad Reza Aghasadeghi, Mojtaba Hamidi-Fard, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 9, pp. 2362-2380
Closed Access | Times Cited: 3
Neda Ahmadi, Mohammad Reza Aghasadeghi, Mojtaba Hamidi-Fard, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 9, pp. 2362-2380
Closed Access | Times Cited: 3
Identification of Antibody-Mediated Hydrolysis Sites of Oligopeptides Corresponding to the SARS-CoV-2 S-Protein by MALDI-TOF Mass Spectrometry
Anna M. Timofeeva, Sergey E. Sedykh, Pavel S. Dmitrenok, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14342-14342
Open Access | Times Cited: 3
Anna M. Timofeeva, Sergey E. Sedykh, Pavel S. Dmitrenok, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14342-14342
Open Access | Times Cited: 3
Chimeric lipoproteins for leptospirosis vaccine: immunogenicity and protective potential
Rafael Carracena de Souza Tapajóz, Francisco Denis Souza Santos, Natasha Rodrigues de Oliveira, et al.
Applied Microbiology and Biotechnology (2024) Vol. 108, Iss. 1
Open Access
Rafael Carracena de Souza Tapajóz, Francisco Denis Souza Santos, Natasha Rodrigues de Oliveira, et al.
Applied Microbiology and Biotechnology (2024) Vol. 108, Iss. 1
Open Access
